standard]
MDVKSGQEPLLSRKEDVVGCGKKRSFWVSSAKVILRVVMWVIFITWAAFI
FLYPSDFVTELYHKWRQATEGTLFGITGSVFLLFSGPILLIAILGSAYIV
LVGEEEIHEKKSSKFPRFRLWTFPVLVDGPFGVVSAAEMIGIVLFTAYVV
WAFAAYTVKNSELVSWFHVPSKERSILMLELAGLRLGMIGLFCTAFLFLP
VARGSVLLRLIDIPFEHATRYHVWLGHLTMLLFTLHGLFYVIGWAIEGRL
ARELMDWKNIGIANLPGVISLLAGLLMWVTSLPGVRRINFELFFYTHQLY
VVFVVFLALHVGDFLFCFAAGGIFLFMLDRFLRFCQSRRTVNILSARSFP
CGTLELVLSKPANLHYNALGWIFLQVRELSWLQWHPFSVSSSPLDGKHHL
AVLIKVLGDWTGKLDRLVSSASEKGTETEHLLQRYPKITASVEGPYGHAS
AYHLTYENLILVAGGIGISPFLAILSDVLHRLKDGKPCMPKNILIVWAIK
TSDELPLLHTVGMESILPNFSNSLNLEIQTYVTRESQPSLEEGKVIEPVN
SAVFPASKGCGMSVLVGTGNIIWSGIYVIVSTVGLVITLALLDVFYINPY
HVSAWWYKGLLFTACMSVSVLIFGGLVIGLWHHWERKTSSHEGKKSIENG
TVKQNEPKMHKDSSKEQYISATRYGQRPDFRGIFETMSDRWGNVDIGVIL
CGPPALQTTVAKECRTQNLKRRGNQAIFHFNSHSFDL
|
IPR000778; Cytochrome b245, heavy chain IPR013112; FAD-binding 8 IPR013121; Ferric reductase, NAD binding IPR013130; Flavoprotein transmembrane component IPR017927; Ferredoxin reductase-type FAD-bindi |